Good Competitors

MUSH Stock

CAD 0.15 0.01 6.25%

Good Shroom competes with Avant Brands, and Aptose Biosciences; as well as few others. The company operates under Beverages sector and is part of Consumer Staples industry. Analyzing Good Shroom competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Good Shroom to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Good Shroom Correlation with its peers.

Good Shroom Correlation With Market

Very poor diversification

The correlation between Good Shroom Co and DJI is 0.8 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Good Shroom Co and DJI in the same portfolio, assuming nothing else is changed.

Moving together with Good Stock

0.76	GOOG	Alphabet CDR	Pair Corr
0.77	GOOG	Alphabet CDR	Pair Corr

Moving against Good Stock

0.74	PAT	Patriot One Technologies Earnings Call This Week	Pair Corr
0.6	MSFT	Microsoft CDR	Pair Corr
0.6	MSFT	Microsoft Corp CDR	Pair Corr
0.38	AAPL	Apple CDR	Pair Corr
0.38	AAPL	Apple Inc CDR	Pair Corr

Return On Tangible Assets is likely to drop to -0.95 in 2026. Return On Capital Employed is likely to drop to -1.33 in 2026. At this time, Good Shroom's Total Current Assets are fairly stable compared to the past year. Total Assets is likely to climb to about 1.3 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 13.8 K in 2026.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.01	0.15	5.74

Details

Intrinsic

Valuation

Low	Real	High
0.01	0.13	5.72

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Good Shroom. Your research has to be compared to or analyzed against Good Shroom's peers to derive any actionable benefits. When done correctly, Good Shroom's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Good Shroom.

Good Shroom Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Good Shroom and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Good and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Good Shroom does not affect the price movement of the other competitor.

	CANB	AVNT	AVCR	TELO	APS
CANB		-0.87	-0.39	0.36	0.14	CANB
AVNT	-0.87		0.25	-0.45	-0.05	AVNT
AVCR	-0.39	0.25		-0.33	0.25	AVCR
TELO	0.36	-0.45	-0.33		-0.28	TELO
APS	0.14	-0.05	0.25	-0.28		APS
	CANB	AVNT	AVCR	TELO	APS

High positive correlations

TELO	+ 0.36	CANB
AVCR	+ 0.25	AVNT
APS	+ 0.25	AVCR
APS	+ 0.14	CANB

High negative correlations

AVNT	- 0.87	CANB
TELO	- 0.45	AVNT
AVCR	- 0.39	CANB
TELO	- 0.33	AVCR
APS	- 0.28	TELO
APS	- 0.05	AVNT

Risk-Adjusted Indicators

There is a big difference between Good Stock performing well and Good Shroom Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Good Shroom's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CANB	4.09	(0.35)	0.00	0.68	0.00	0.00	20.00	(16.67)	41.67
AVNT	3.80	0.54	0.11	0.99	4.02	(5.07)	8.33	(7.61)	27.67
AVCR	4.72	0.91	0.09	(0.55)	4.19	(10.57)	12.50	(9.09)	30.00
TELO	4.73	0.20	0.01	(0.36)	5.71	(14.37)	12.50	(11.11)	43.18
APS	1.94	0.34	0.08	(0.37)	2.25	(2.44)	5.36	(4.29)	14.67

Good Shroom Competitive Analysis

The better you understand Good Shroom competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Good Shroom's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Good Shroom's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	MUSH	CANB	AVNT	AVCR	TELO	APS
	6.25 0.15 Good	16.67 0.03 CanadaBis	1.12 0.88 Avant	7.14 0.07 Avricore	25.00 0.05 Telo	0.44 2.26 Aptose
Market Volatility (90 Days Market Risk)	Out of control	Out of control	Abnormally volatile	Out of control	Out of control	Risky
Market Performance (90 Days Performance)	Good	Weakest	Fair	Fair	Weakest	Mild
Odds of Financial Distress (Probability Of Bankruptcy)	Small	High	Small	Average	Risky	High
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Fairly Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Sell	Strong Sell	Cautious Hold	Strong Sell	Strong Sell	Strong Sell
Current Ratio	9.45 X	6.06 X	N/A	1.80 X	0.09 X	11.27 X
Net Asset	1.02 M	24.54 M	59.47 M	2.3 M	911.3 K	10.13 M
Profit Margin	(0.16) %	(0.09) %	(0.53) %	(0.85) %	N/A	N/A
EBITDA	(450.79 K)	481.72 K	(19.45 M)	(578.03 K)	(2.67 M)	(26.23 M)
Operating Margin	(0.18) %	0.04 %	(0.14) %	(9.88) %	N/A	N/A
Current Valuation	7.77 M	10.1 M	23.92 M	7.35 M	3.76 M	30.76 M
Price To Book	77.05 X	0.46 X	0.36 X	5.87 X	6.26 X	68.22 X
Retained Earnings	(13.17 M)	(13.39 M)	(88.01 M)	(32.4 M)	(30.55 M)	(540.97 M)
Beta	-3.24	0.36	3.53	0.19	0.035	0.59
Number Of Employees	N/A	N/A	180	N/A	N/A	13
Shares Outstanding	51.67 M	141.02 M	11.2 M	101.29 M	100.43 M	2.55 M
Cash Flow From Operations	210.6 K	(3.2 M)	507 K	1 M	(2.33 M)	(35.98 M)
Total Debt	778.53 K	4.61 M	17.01 M	330.82 K	396.32 K	10.64 M
Return On Equity	-1.57	-0.16	-0.55	-0.86	-520.01	-6.94
Return On Asset	-0.24	0.0038	-0.1	-0.23	-3.21	-1.41
Number Of Shares Shorted	11.46 K	1.41 K	1.15 K	15.31 K	436	140
Book Value Per Share	0 X	0.06 X	2.41 X	0.01 X	N/A	(10.37) X
Total Asset	1.02 M	24.54 M	59.47 M	2.3 M	911.3 K	10.13 M
Debt To Equity	0.14 %	25.30 %	N/A	N/A	N/A	5.00 %
Short Ratio	0.19 X	0.03 X	0.54 X	0.16 X	0.03 X	0.07 X
Target Price	N/A	N/A	N/A	N/A	N/A	2.32
Shares Owned By Institutions	N/A	N/A	N/A	N/A	0.39 %	3.91 %
Market Capitalization	8.01 M	3.53 M	7.39 M	7.6 M	5.02 M	5.77 M
Price To Earning	N/A	N/A	N/A	N/A	N/A	(1.85) X
Price To Sales	2.59 X	0.23 X	0.26 X	3.95 X	N/A	N/A
Net Income	(412.31 K)	(835.2 K)	(22.55 M)	(668.98 K)	(2.72 M)	(25.43 M)
Earnings Per Share	(0.01) X	(0.01) X	(1.97) X	(0.02) X	(0.03) X	0.94 X
Shares Owned By Insiders	38.03 %	67.58 %	12.13 %	9.58 %	2.97 %	20.24 %
Revenue	3 M	16.9 M	35.8 M	4.79 M	N/A	N/A
Working Capital	225.91 K	845.17 K	11.26 M	1.25 M	495.94 K	5.07 M
Cash And Equivalents	2.26 M	1.84 M	1.74 M	122.09 K	24.25 K	36.37 M
Cash Per Share	0.05 X	0.02 X	N/A	N/A	N/A	0.64 X
Gross Profit	498.06 K	6.73 M	1.33 M	835.53 K	N/A	N/A
Day Typical Price	0.15	0.025	0.88	0.075	0.05	2.27
Accumulation Distribution	N/A	N/A	N/A	N/A	N/A	5.23
Market Facilitation Index	N/A	N/A	N/A	N/A	N/A	1.0E-4
Daily Balance Of Power	0	0	0	9.2 T	9.2 T	0.25
Period Momentum Indicator	(0.01)	(0.01)	(0.01)	0.005	0.01	0.01
Rate Of Daily Change	0.94	0.83	0.99	1.07	1.25	1.0
Day Median Price	0.15	0.025	0.88	0.075	0.05	2.28
Price Action Indicator	(0.01)	(0)	(0.01)	0.0025	0.005	(0.01)
Coefficient Of Variation	592.16	(2,184)	872.98	808.97	4577.22	917.35
Mean Deviation	3.44	4.09	3.8	4.72	4.73	1.94
Jensen Alpha	0.8457	(0.35)	0.5427	0.9108	0.1981	0.337
Total Risk Alpha	0.503	(1.00)	0.1966	0.3216	(0.44)	0.0856
Sortino Ratio	0.1068	N/A	0.106	0.0947	0.009	0.0771
Downside Variance	62.73	N/A	23.86	64.54	147.42	8.93
Standard Deviation	5.42	8.23	5.13	6.72	8.22	2.75
Kurtosis	3.65	2.57	1.33	0.7906	1.91	1.47
Potential Upside	9.09	20.0	8.33	12.5	12.5	5.36
Treynor Ratio	0.9036	0.6825	0.9873	(0.55)	(0.36)	(0.37)
Maximum Drawdown	34.72	41.67	27.67	30.0	43.18	14.67
Variance	29.41	67.81	26.33	45.18	67.55	7.58
Market Risk Adjusted Performance	0.9136	0.6925	0.9973	(0.54)	(0.35)	(0.36)
Risk Adjusted Performance	0.1448	(0.03)	0.1009	0.1085	0.0266	0.095
Skewness	1.15	0.4305	0.4192	0.7765	0.703	0.5133
Semi Deviation	2.95	N/A	4.02	4.19	5.71	2.25
Information Ratio	0.156	(0.05)	0.1009	0.1132	0.0133	0.0836
Value At Risk	(7.14)	(16.67)	(7.61)	(9.09)	(11.11)	(4.29)
Expected Short fall	(9.64)	N/A	(5.07)	(10.57)	(14.37)	(2.44)
Downside Deviation	7.92	N/A	4.89	8.03	12.14	2.99
Semi Variance	8.72	N/A	16.17	17.59	32.58	5.05

Good Shroom Competition Performance Charts

Five steps to successful analysis of Good Shroom Competition

Good Shroom's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Good Shroom in relation to its competition. Good Shroom's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Good Shroom in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Good Shroom's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Good Shroom, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Good Shroom position

In addition to having Good Shroom in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Convertibles Funds Thematic Idea Now

Convertibles Funds

Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 25 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for Good Stock Analysis

When running Good Shroom's price analysis, check to measure Good Shroom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Good Shroom is operating at the current time. Most of Good Shroom's value examination focuses on studying past and present price action to predict the probability of Good Shroom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Good Shroom's price. Additionally, you may evaluate how the addition of Good Shroom to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC